JPS5835537B2 - Vinyl chloride resin composition and its manufacturing method - Google Patents
Vinyl chloride resin composition and its manufacturing methodInfo
- Publication number
- JPS5835537B2 JPS5835537B2 JP53104559A JP10455978A JPS5835537B2 JP S5835537 B2 JPS5835537 B2 JP S5835537B2 JP 53104559 A JP53104559 A JP 53104559A JP 10455978 A JP10455978 A JP 10455978A JP S5835537 B2 JPS5835537 B2 JP S5835537B2
- Authority
- JP
- Japan
- Prior art keywords
- vinyl chloride
- chloride resin
- weight
- resin
- plasticizer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- External Artificial Organs (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
【発明の詳細な説明】
この発明はペースト用樹脂を除く塩化ビニル系樹脂(以
下、単に塩化ビニル系樹脂という。DETAILED DESCRIPTION OF THE INVENTION This invention applies to vinyl chloride resins (hereinafter simply referred to as vinyl chloride resins) other than paste resins.
)に対する添加剤、特に可塑剤の溶出が少なく、かつ血
液に対する悪影響の少ない塩化ビニル系樹脂組成物およ
びその製造方法に関する。The present invention relates to a vinyl chloride resin composition which has little elution of additives, particularly plasticizers, and which has little adverse effect on blood, and a method for producing the same.
従来、塩化ビニル系樹脂に対し、種々の添加剤が使用さ
れている。Conventionally, various additives have been used for vinyl chloride resins.
特に可塑剤は塩化ビニル樹脂を軟質化するため多量に使
用される。In particular, plasticizers are used in large amounts to soften vinyl chloride resins.
このような塩化ビニル樹脂が特に食品容器、医療用器具
等に使用される場合、これら添加物はできるだけ人体に
無害なものが選ばれるが、ある種の添加物はのちの研究
によって有害であると判明する場合も考えられる。When such vinyl chloride resin is used in food containers, medical equipment, etc., additives are selected to be as harmless to the human body as possible, but later research has shown that some additives are harmful. It is possible that it may become clear.
したがって、添加物は使用環境において、できるだけ溶
出しないようにすることが望ましい。Therefore, it is desirable to prevent additives from eluting as much as possible in the usage environment.
たとえば、可塑剤として、フタル酸エステルが使用され
ているが、これを含む塩化ビニル樹脂製品を水等の溶剤
に接触させた場合、この可塑剤が徐々に溶出することが
知られている。For example, phthalic acid ester is used as a plasticizer, but it is known that when a vinyl chloride resin product containing this ester is brought into contact with a solvent such as water, the plasticizer gradually dissolves out.
この溶出したフクル酸エステルが生体内に導入された場
合、これが健康に影響を及ぼすという明確な証明は未だ
ないが、その溶出をできるだけ防止することは医学上か
ら、その必要性が重視されている。Although there is still no clear proof that this eluted fuculate ester affects health when introduced into living organisms, it is important from a medical standpoint to prevent its elution as much as possible. .
また、従来より、非移行性可塑剤があるけれども、粘性
が高いために加工性が低いこと、分子量が大きいこと、
一般にポリエステル系であるためケン化されやすいこと
、軟化しにくいことなどにより、医療用、食品用に使用
する可塑剤としては適さない。In addition, although there are conventional non-migratory plasticizers, they have low processability due to high viscosity, large molecular weight,
Generally, since it is polyester-based, it is easily saponified and difficult to soften, so it is not suitable as a plasticizer for medical or food applications.
しかして、この発明の目的とするところは塩化ビニル系
樹脂に対する添加剤、特に可塑剤の溶出を防止すること
ができ、かつ血液に対し、悪影響が少なく、食品、飲料
用容器、医療用器具等の用途にも安心して使用できる塩
化ビニル系樹脂組酸物、該樹脂組成物からつくられる医
療器具および該樹脂組成物の製造方法を提供することで
ある。Therefore, the purpose of this invention is to be able to prevent the elution of additives, especially plasticizers, to vinyl chloride resins, and to have little adverse effect on blood, such as foods, beverage containers, medical instruments, etc. It is an object of the present invention to provide a vinyl chloride-based resin composite acid that can be safely used in applications such as medical devices made from the resin composition, and a method for producing the resin composition.
本発明者等は従来の添加剤とともにシリコーンオイルを
塩化ビニル系樹脂に含有させることによって、添加剤の
溶出を著るしく防止し得ることを見出し、本発明に到達
した。The present inventors have discovered that by incorporating silicone oil into a vinyl chloride resin together with conventional additives, the elution of additives can be significantly prevented, and the present invention has been achieved.
すなわち、この発明は、ペースト用樹脂を除く塩化ビニ
ル系樹脂と、該樹脂に対して、20ない、し80重量%
添加された可塑剤と、その他添加剤からなる塩化ビニル
系樹脂組成物lこおいて、ポリメチルフェニルシロキサ
ンポリジメチルシロキサン、ポリメチルハイドロジエン
シスキサンのうちから選ばれる少なくとも一種のシリコ
ーンオイルを上記塩化ビニル系樹脂に対して0.2ない
し7重量%含有し、かつ該組成物から得られた成形物を
60℃、15重量%ラウリル硫酸ナトリウム水溶液に9
6時間浸漬後の溶出物の全可塑剤に対する溶出率が40
%以下であり、さらに上記組成物20gを200m1の
水に浸し121℃で20分間加熱したのちの上記水の過
マンガン酸カリウム消費量が0.50 (17100モ
ル過マンガン酸カリウム消費量)以下であることを特徴
とする医療用として有用な塩化ビニル系樹脂組成物であ
る。That is, the present invention includes a vinyl chloride resin other than a paste resin, and 20 to 80% by weight of the resin.
In a vinyl chloride resin composition consisting of an added plasticizer and other additives, at least one silicone oil selected from polymethylphenylsiloxane, polydimethylsiloxane, and polymethylhydrogen siloxane is chlorinated. It contains 0.2 to 7% by weight based on the vinyl resin, and a molded product obtained from the composition is added to a 15% by weight aqueous sodium lauryl sulfate solution at 60°C for 90 minutes.
The elution ratio of the eluate to the total plasticizer after 6 hours of immersion is 40
% or less, and furthermore, the potassium permanganate consumption in the water after immersing 20 g of the above composition in 200 ml of water and heating it at 121 ° C. for 20 minutes is 0.50 (17100 mol potassium permanganate consumption) or less. This is a vinyl chloride resin composition useful for medical purposes.
この発明lこ係わる塩化ビニル系樹脂の製造法において
、シリコーンオイルは予め可塑剤の一部と乳化せしめた
のち、これに同じく可塑剤を添加した塩化ビニル系樹脂
に添加し、そののち混合、加熱する。In the method for producing vinyl chloride resin according to this invention, silicone oil is emulsified with a portion of a plasticizer in advance, and then added to the vinyl chloride resin to which a plasticizer has also been added, and then mixed and heated. do.
なお、この明細書tζおいて、塩化ビニル系樹脂とは塩
化ビニル樹脂、ポリ塩化ビニリチン、あるいはポリ塩化
ビニルの共重合体(三元共重合体も含む)あるいはポリ
塩化ビニルを主体とし、これと他のポリマーとのブレン
ドも含む概念である。In this specification tζ, vinyl chloride resin refers to vinyl chloride resin, polyvinyritine chloride, copolymers (including terpolymers) of polyvinyl chloride, or polyvinyl chloride as a main component, and The concept also includes blends with other polymers.
ポリ塩化ビニルの共重合体を形成し得るコモノマートシ
ては、ビニルエステル、ビニルエーテル、ビニリデンク
ロリド等のビニリチン化合物、低級オレフィン、酢酸ビ
ニル、臭化ビニル、弗化ビニル、芳香族化合物(たとえ
ばスチレン)、環状不飽和化合物(たとえばビニルピリ
ジン)、アクリル酸およびその誘導体、ブタジェン等の
共役不飽和化合物等である。Comonomers that can form copolymers of polyvinyl chloride include vinyl esters, vinyl ethers, vinylitine compounds such as vinylidene chloride, lower olefins, vinyl acetate, vinyl bromide, vinyl fluoride, aromatic compounds (such as styrene), These include cyclic unsaturated compounds (for example, vinylpyridine), acrylic acid and its derivatives, and conjugated unsaturated compounds such as butadiene.
ポリ塩化ビニルとブレンドされる他ポリマーの例トして
はスチレン−アクリロニトリル共重合体、スチレンーメ
チルメククリレート共重合体等である。Examples of other polymers that may be blended with polyvinyl chloride include styrene-acrylonitrile copolymer, styrene-methyl meccrylate copolymer, and the like.
塩化ビニル系樹脂に添加されるシリコーンオイルについ
てはポリメチルフェニルシロキサン、ポリジメチルシロ
キサンおよびポリメチルハイドロジエンシロキサン、の
うちから選ばれる少なくとも一種を使用する。As for the silicone oil added to the vinyl chloride resin, at least one selected from polymethylphenylsiloxane, polydimethylsiloxane, and polymethylhydrogensiloxane is used.
シリコーンオイルを塩化ビニル系樹脂に添加する場合、
シリコーンオイルが塩化ビニル系樹脂との親和性1こ乏
しいため、直接混入すると十分な分散が得られないが、
予め比較的親和性の良い可塑剤と混和してから添加する
ことtこよって樹脂中tこ良好tこ分散させ、樹脂表面
をコートすることができる。When adding silicone oil to vinyl chloride resin,
Since silicone oil has poor affinity with vinyl chloride resin, sufficient dispersion cannot be obtained if it is directly mixed.
By mixing the resin with a plasticizer with relatively good affinity before adding it, the resin can be well dispersed in the resin and the resin surface can be coated.
前記シリコーンオイルの添加量については、塩化ビニル
系樹脂に対し、0.2ないし7重量%、好ましくは工な
いし4重量%である。The amount of the silicone oil added is 0.2 to 7% by weight, preferably 1 to 4% by weight, based on the vinyl chloride resin.
シリコーン添加量が0.2重量%以下のときは可塑剤等
の添加剤の溶出防止効果が十分でなく、逆に7重量%以
上のときは成形加工上困難をともなうほか、塩化ビニル
系樹脂との混和が悪くなり、均質な塩化ビニル系樹脂製
品が得られない。If the amount of silicone added is less than 0.2% by weight, the effect of preventing the elution of additives such as plasticizers will not be sufficient, and if it is more than 7% by weight, it will not only be difficult to mold, but also be difficult to prevent from vinyl chloride resin. Mixing becomes poor, making it impossible to obtain a homogeneous vinyl chloride resin product.
なお、可塑剤はポリ塩化ビニル100重量部1ζ対して
、通常20ないし80重量部添加されるが、傾向として
は可塑剤の増加にともなって、シリコーン添加量も増加
すせることが好ましい。The plasticizer is usually added in an amount of 20 to 80 parts by weight per 1ζ of 100 parts by weight of polyvinyl chloride, but it is preferable that as the amount of plasticizer increases, the amount of silicone added also increases.
従来、使用されている可塑剤等の添加剤の種類、添加量
については従来通り使用してよい。The types and amounts of additives such as plasticizers that have been used in the past may be used as usual.
なお、滑剤についてはシリコーンオイル自体、滑剤とし
ての作用を有するので、%lこ他の滑剤の添加を省略す
ることもできる。As for the lubricant, since silicone oil itself has a lubricant effect, addition of other lubricants such as %l can be omitted.
実施例
下記表1に示す配合からなるポリ塩化ビニルペレットを
それぞれつくり、ついで、これらを厚さ**0.4mm
のシート状に成形した。Example: Polyvinyl chloride pellets having the formulations shown in Table 1 below were made, and then these were made to a thickness of **0.4 mm.
It was formed into a sheet.
表中、添加量の数値は重量部を示す。In the table, the numerical values for the amounts added indicate parts by weight.
また、実施例1〜8において、シリコーンオイルは可塑
剤20重量部と予め混合したのち、塩化ビニル樹脂に添
加した。Moreover, in Examples 1 to 8, the silicone oil was mixed in advance with 20 parts by weight of a plasticizer, and then added to the vinyl chloride resin.
つぎに、各実施例および参考例のものの各シート状試料
20gをそれぞれ200m1の水に浸し、オートクレー
ブを用いて、121℃で20分間加熱したのち放冷した
。Next, 20 g of each sheet-like sample of each Example and Reference Example was immersed in 200 ml of water, heated in an autoclave at 121° C. for 20 minutes, and then allowed to cool.
これらを検液として、所定の試験方法に基づき、過マン
ガン酸カリウム消費量を測定した。Using these as test solutions, the amount of potassium permanganate consumed was measured based on a predetermined test method.
その結果を表2に示す。つぎに実施例1〜8、参考例1
の試料から試験片を切りとり、これをラウリル硫酸ナト
リウム水溶液(15重量%)に浸漬し、60℃にて24
時間および96時間放置し、それぞれの重量変化を測定
した。The results are shown in Table 2. Next, Examples 1 to 8, Reference Example 1
A test piece was cut from the sample, immersed in a sodium lauryl sulfate aqueous solution (15% by weight), and heated at 60°C for 24 hours.
The samples were left to stand for 96 hours, and the weight changes were measured.
その結果を表3に示す。さらに各実施例のシートについ
て、毒性試験、溶出物試験、滅菌処理の影響について、
所定の試験方法に基づいてそれぞれ実施した。The results are shown in Table 3. Furthermore, regarding the sheets of each example, regarding the effects of toxicity tests, eluate tests, and sterilization treatment,
Each test was conducted based on a prescribed test method.
その結果を実施例1〜3、について下記表4に示す。The results are shown in Table 4 below for Examples 1 to 3.
なお、省略した実施例4〜8、についてもこの表4に示
すとほぼ同様の結果が得られた。In addition, as shown in this Table 4, almost the same results were obtained for Examples 4 to 8, which were omitted.
なお己記表中(ハ)は毒性を認めないことを意味する。Note that (c) in the personal statement means that no toxicity is recognized.
また、収縮率の「横」とは延伸方向、「縦」とは延伸方
向と直角の
方向を意味する。Further, in shrinkage percentage, "horizontal" means the direction of stretching, and "vertical" means the direction perpendicular to the stretching direction.
(注2)表2の(注1)に示す厚生省告示の試験方法に
よる。(Note 2) Based on the test method announced by the Ministry of Health and Welfare shown in (Note 1) in Table 2.
つぎに実施例5,7のシートについて100%モジュラ
ス、引張り強度、高周波シールによるシール強度につい
ても、それぞれ試験した。Next, the sheets of Examples 5 and 7 were also tested for 100% modulus, tensile strength, and seal strength by high frequency sealing.
その結果を表5に示す。The results are shown in Table 5.
シール強度の高周波シール条件:
電気入カ一定、シール面積 20X8(間)水蒸気透過
:
温度 20℃、湿度 65%、14日間放置(注3)
(JIS−に−6723軟質塩化ビニルコンパウンド)
の規格を準用した。High-frequency seal conditions for seal strength: Constant electrical input, seal area 20 x 8 (distance) Water vapor transmission: Temperature 20°C, humidity 65%, left for 14 days (Note 3)
(JIS-ni-6723 soft vinyl chloride compound)
The standards were applied mutatis mutandis.
さらに実施例5,7について下記表6に示す機能試験を
おこない、その結果を表6に示す。Furthermore, the functional tests shown in Table 6 below were conducted for Examples 5 and 7, and the results are shown in Table 6.
表 6(機能試験結果)
(表2 注1に示す厚生省告示による試験)Serra
tiamar
TGC131T、 7日間
Cladosporium
Candida。Table 6 (Functional test results) (Test according to the Ministry of Health and Welfare notification shown in Table 2 Note 1) Serra
tiamar TGC131T, 7 days Cladosporium Candida.
Curvalaria。Curvalaria.
培地、PDA、3叱、■2的 微生物透過試験二使用菌。Medium, PDA, 3 scolding, ■2 target Two bacteria used in microbial penetration test.
培地。Culture medium.
かび抵抗試験:使用かび。Mold resistance test: Use mold.
(規格外)
さらに、牛血漿による可塑剤溶出試験を実施例5、参考
例4についておこない、その結果を表7に示す。(Out of specification) Furthermore, a plasticizer elution test using bovine plasma was conducted for Example 5 and Reference Example 4, and the results are shown in Table 7.
その他、赤血球生存試験、トリグリセライド定量試験、
U■吸収試験、血小板生存試験(リースエラカー法)、
血液凝固試験、血清保存試験についておこなった結果、
全く異常はなかった。Others include red blood cell survival test, triglyceride quantitative test,
U ■ Absorption test, platelet survival test (Ries Elaker method),
As a result of blood coagulation test and serum preservation test,
There was nothing abnormal at all.
これらの総ての試験結果から明らかなように、各実施例
に係わる塩化ビニル樹脂はシリコーンオイルを含まない
参考例のものと比較して可塑剤等の添加物の溶出が著る
しく抑制されるとともに、血液に対する悪影響が少なく
、医療用器具、たとえは人工じん臓用血液回路、人工心
肺、カテーテル、血液バッグ等として好適なものである
。As is clear from all of these test results, the vinyl chloride resins according to each example significantly suppress the elution of additives such as plasticizers compared to the reference example that does not contain silicone oil. In addition, it has little adverse effect on blood, and is suitable for medical equipment, such as artificial kidney blood circuits, artificial heart-lung machines, catheters, blood bags, etc.
なお、上記実施例では塩化ビニル系樹脂として、塩化ビ
ニル樹脂について、実施した例を示したが、他の塩化ビ
ニル系樹脂の場合でも、同様の効果が得られた。In addition, in the above-mentioned example, an example was shown in which vinyl chloride resin was used as the vinyl chloride resin, but similar effects were obtained in the case of other vinyl chloride resins.
以上説明したように、この発明によれば、可塑剤等の添
加剤の溶出を著るしく抑制し得る塩化ビニル系樹脂を得
ることができる。As explained above, according to the present invention, it is possible to obtain a vinyl chloride resin that can significantly suppress the elution of additives such as plasticizers.
したがって特に食品容器、生理学的溶液の収集、貯ぞう
、投与等に使用される医療用器具等に好適するほか、耐
候性、疎水性、耐油性等にすぐれるため、電線等の被覆
にも好適する。Therefore, it is particularly suitable for food containers, medical instruments used for collecting, storing, and administering physiological solutions, etc., and is also suitable for covering electric wires, etc. due to its excellent weather resistance, hydrophobicity, and oil resistance. do.
Claims (1)
に対して、20ないし80重量%添加された可塑剤と、
その他添加剤からなる塩化ビニル系樹脂組成物において
、ポリメチルフエニlレシロキサンポリジメチルシロキ
サン、ポリメチルハイドロジエンシスキサンのうちから
選ばれる少なくとも一種のシリコーンオイルを上記塩化
ビニル系樹脂に対して0.2ないし7重量%含有し、か
つ該組成物から得られた成形物を60℃、15重量%ラ
ウリル硫酸ナトリウム水溶液に96時間浸漬後の溶出物
の全可塑剤に対する溶出率が40%以下であり、さらに
上記組成物20gを200 mlの水に浸し121℃で
20分間加熱したのちの上記水の過マンガン酸カリウム
消費量が0.50(17100モル過マンガン酸カリウ
ム消費量)以下であることを特徴とする医療用として有
用な塩化ビニル系樹脂組成物。 2 ポリメチルフェニルシロキサン、ポリジメチルシロ
キ叫ンおよびポリハイドロジエンシロキサンのうちから
選ばれる少なくとも一種のシリコーンオイルをペースト
用樹脂を除く塩化ビニル系樹脂に対し0.2ないし7重
量%、可塑剤の一部と乳化せしめたのち、この乳化化合
物をあらかじめ上記可塑剤の残部と上記塩化ビニル系樹
脂との混合物中に添加し、ついで加熱混合することより
なる、酸形後60℃、15重量%ラウリル硫酸す) I
Jウム水溶液に96時間浸漬した後の溶出物の全可塑剤
に対する溶出率が40%以下であり、かつ、成形物20
gを200m1の水に浸し121℃で20分間加熱した
のちの上記水の過マンガン酸カリウム消費量が0.50
(1/100モル過マンガン酸カリウム消費量)以下で
あるような医療用として有用な塩化ビニル系樹脂組成物
の製造方法。[Scope of Claims] 1. A vinyl chloride resin other than a paste resin, a plasticizer added to the resin in an amount of 20 to 80% by weight,
In a vinyl chloride-based resin composition comprising other additives, at least one silicone oil selected from polymethylphenylresiloxane, polydimethylsiloxane, and polymethylhydrodiene siskisane is added in an amount of 0.2 to 0.2% based on the vinyl chloride resin. 7% by weight, and after immersing a molded product obtained from the composition in a 15% by weight sodium lauryl sulfate aqueous solution at 60°C for 96 hours, the elution rate of the eluate based on the total plasticizer is 40% or less, and It is characterized in that after immersing 20 g of the above composition in 200 ml of water and heating it at 121° C. for 20 minutes, the amount of potassium permanganate consumed in the water is 0.50 (17,100 mol potassium permanganate consumed) or less. A vinyl chloride resin composition useful for medical purposes. 2 0.2 to 7% by weight of at least one silicone oil selected from polymethylphenylsiloxane, polydimethylsiloxane, and polyhydrogensiloxane, based on the vinyl chloride resin excluding the paste resin, and one part of the plasticizer. 15% by weight lauryl sulfate at 60° C. )I
The elution rate of the eluate based on the total plasticizer after immersion in the Jum aqueous solution for 96 hours is 40% or less, and the molded product 20
g in 200ml of water and heated at 121°C for 20 minutes, the consumption of potassium permanganate in the water is 0.50.
(1/100 mole potassium permanganate consumption) or less, a method for producing a vinyl chloride resin composition useful for medical use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53104559A JPS5835537B2 (en) | 1978-08-28 | 1978-08-28 | Vinyl chloride resin composition and its manufacturing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53104559A JPS5835537B2 (en) | 1978-08-28 | 1978-08-28 | Vinyl chloride resin composition and its manufacturing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5445354A JPS5445354A (en) | 1979-04-10 |
| JPS5835537B2 true JPS5835537B2 (en) | 1983-08-03 |
Family
ID=14383808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53104559A Expired JPS5835537B2 (en) | 1978-08-28 | 1978-08-28 | Vinyl chloride resin composition and its manufacturing method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5835537B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5697497A (en) * | 1979-12-28 | 1981-08-06 | Tokyo Shibaura Electric Co | Drain hose for washing machine* etc* |
-
1978
- 1978-08-28 JP JP53104559A patent/JPS5835537B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5445354A (en) | 1979-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4177182A (en) | Polyvinyl chloride series resin medical product implements and method of manufacturing the same using siloxane oil additive | |
| Brash et al. | Protein adsorption studies on'standard'polymeric materials | |
| WO2012169081A1 (en) | Vinyl chloride resin composition | |
| CH617856A5 (en) | ||
| Lakshmi et al. | Synthesis, surface properties and performance of thiosulphate-substituted plasticized poly (vinyl chloride) | |
| JPS5835537B2 (en) | Vinyl chloride resin composition and its manufacturing method | |
| Zhao et al. | Update on medical plasticised PVC | |
| JPH01178541A (en) | Low elution pharmaceutical liquids, infusions, and blood transfusion devices | |
| JPS5933343A (en) | Vinyl chloride resin composition | |
| JPS6128541A (en) | Vinyl chloride resin composition for medical equipment | |
| US20020156159A1 (en) | Viscosity enhanced natural rubber latex dipping media and dipped articles of greater thickness prepared therefrom | |
| EP0305346B1 (en) | Articles exhibiting a blood-compatible surface layer and process for providing articles with such a surface layer | |
| EP0108955B1 (en) | Medical articles | |
| JPS5822222B2 (en) | Blood treatment parts made of vinyl chloride resin | |
| JPH0314066B2 (en) | ||
| JPH038778B2 (en) | ||
| JPS5967959A (en) | Soft medical instrument | |
| JP3243348B2 (en) | Medical equipment | |
| Haberey et al. | Cardiovascular effects of iohexol in the rat and the isolated rabbit heart | |
| JPS5968362A (en) | Thermoplastic resin composition | |
| JPS6096623A (en) | Production of resin molding | |
| JP3447391B2 (en) | Medical equipment | |
| JPS6048993A (en) | Sugar fatty acid ester and transfusion containing the same | |
| JPH0112673B2 (en) | ||
| Bagheri et al. | Effects of different kinds of stabilizers on thermal stability, biocompatibility and blood compatibility of PVC film sterilized by ethylene oxide for blood bag |